At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies that advance the existing standard of care, and enrich the lives and treatment alternatives for patients worldwide.
Read more →
Transcript
Press Release (URL)
Webcast
GAAP to Non-GAAP Recs
Quarterly Summary
Form 10-Q